Cathie Wood’s ARK Invest Buys Over 2.1 Million Shares of Ginkgo Bioworks

Photo of Chris Lange
By Chris Lange Published
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
Cathie Wood’s ARK Invest Buys Over 2.1 Million Shares of Ginkgo Bioworks

© vchal / Getty Images

A couple of ARK Invest exchange-traded funds run by ETF star Cathie Wood made a huge buy on Thursday. Specifically, these funds bought roughly $15 million worth of Ginkgo Bioworks Holdings Inc. (NYSE: DNA), as the prices of these ETFs were down on Thursday.
[in-text-ad]
ARK Genomic Revolution ETF (NYSEARCA: ARKG) bought 698,931 shares, while ARK Innovation ETF (NYSEARCA: ARKK | ARKK Price Prediction) bought 1,426,097 shares. At Thursday’s closing price, this would have valued the sales at roughly $14.7 million altogether. Even though this is a small fraction of their total holdings, every little bit counts. The Genomic Revolution ETF is down more than 46% and the other is down 38% in the past year.
[nativounit]
Check out all the ARK Invest purchases for Thursday as well:

Fund Ticker Name Shares
ARKG BNR BURNING ROCK BIOTECH 4,000
ARKG DNA GINKGO BIOWORKS 698,931
ARKG NRIX NURIX THERAPEUTICS 44,628
ARKG NTLA INTELLIA THERAPEUTICS 25,739
ARKG PSNL PERSONALIS 59,000
ARKG QSI QUANTUM-SI 101,895
ARKG RXRX RECURSION PHARMACEUTICALS 28,000
ARKK SQ BLOCK 121,727
ARKK PLTR PALANTIR TECHNOLOGIES 430,339
ARKK PATH UIPATH 184,626
ARKK NVTA INVITAE 57,198
ARKK NTLA INTELLIA THERAPEUTICS 63,440
ARKK VCYT VERACYTE 29,411
ARKK HOOD ROBINHOOD MARKETS 487,263
ARKK ZM ZOOM VIDEO COMMUNICATIONS 43,550
ARKK DNA GINKGO BIOWORKS 1,426,097
ARKK COIN COINBASE GLOBAL 35,390
ARKK CGEN COMPUGEN 89,164
ARKK BEAM BEAM THERAPEUTICS 42,300
ARKK TWLO TWILIO 32,533
ARKQ AVAV AEROVIRONMENT 20,101
ARKW ROKU ROKU 18,074
ARKW TWOU 2U 13,011
ARKX MKFG MARKFORGED 34,624

Catherine Wood, the CEO and CIO of ARK Investment Management, is a minority and nonvoting shareholder of 24/7 Wall St., owner of a673b.bigscoots-temp.com.
[recirclink id=1025172][wallst_email_signup]

Photo of Chris Lange
About the Author Chris Lange →

Chris Lange is a writer for 24/7 Wall St., based in Houston. He has covered financial markets over the past decade with an emphasis on healthcare, tech, and IPOs. During this time, he has published thousands of articles with insightful analysis across these complex fields. Currently, Lange's focus is on military and geopolitical topics.

Lange's work has been quoted or mentioned in Forbes, The New York Times, Business Insider, USA Today, MSN, Yahoo, The Verge, Vice, The Intelligencer, Quartz, Nasdaq, The Motley Fool, Fox Business, International Business Times, The Street, Seeking Alpha, Barron’s, Benzinga, and many other major publications.

A graduate of Southwestern University in Georgetown, Texas, Lange majored in business with a particular focus on investments. He has previous experience in the banking industry and startups.

Featured Reads

Our top personal finance-related articles today. Your wallet will thank you later.

Continue Reading

Top Gaining Stocks

CBOE Vol: 1,568,143
PSKY Vol: 12,285,993
STX Vol: 7,378,346
ORCL Vol: 26,317,675
DDOG Vol: 6,247,779

Top Losing Stocks

LKQ
LKQ Vol: 4,367,433
CLX Vol: 13,260,523
SYK Vol: 4,519,455
MHK Vol: 1,859,865
AMGN Vol: 3,818,618